“e4life” is Present at Expomed Eurasia with its Innovative Device Able to Inactivate Flu and Covid Viruses With an Efficacy over 90%
19 Abril 2024 - 10:13AM
Business Wire
Expomed Eurasia, the most important medical exhibition
between Europe and Asia, is ready to house more than a hundred
companies, to discover new technological trends and the most
innovative products which are going to change deeply the health
market.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240419226980/en/
e4life: e4ambient and e4you devices
(Photo: Business Wire)
This is a perfect occasion for e4life to present its
device based on the e4shield technology which is able to
inactivate flu and Covid viruses present in the air. A technology,
patented in Italy, that uses neither chemical agents nor
filtering materials, but it is based on the transmission of
electromagnetic waves able to inactivate the viral load in
aerosol.
“This Exhibition represents an extraordinary opportunity to
present our innovative technology (e4shield) in a dynamic and
rapidly evolving region as Eurasia. In a climate of growing
consciousness of the importance of health and of the diseases’
prevention, there is a growing need for smart and technologically
advanced solutions that can guarantee safe environments for people.
e4life, with its extremely innovative technology, represents the
most effective answer to this need. The features of our devices are
unique in the market and can enormously contribute in improving
people health and wellbeing” explains Vincenzo Pompa, CEO of
e4life.
e4life has been launched thanks to a joint venture
between two global leaders: ELT Group, world leader for over 70
years in Electronic Defense systems, and Lendlease,
specialized in major urban regeneration projects.
The e4shield technology, which is the core of
e4life, was given birth during the Covid period thanks to
the initiative of a researcher of the ELT Group who explored the
use of electromagnetic fields to inactivate viruses. Based on
research by a group of Taiwanese scientists published in the
scientific journal Nature, he began to get his first results by
testing different frequencies of electromagnetic waves at first on
Covid-19 and later on other Coronaviruses.
The devices distributed by e4life guarantee an efficacy
over 90% and their inactivation power is almost
instantaneous. During their use it is not necessary to evacuate the
rooms, because it is harmless to humans and animals. The
electromagnetic impulses used are safe. This applies both to the
environmental version of the device (e4ambient), which acts
in an area of about 50 square meters, and to the wearable release
(e4you), CE and SAR certified, which guarantees that the
device can be worn for as long as wished without any risks for the
health.
The technology utilized in e4life devices has been tested
under rigorous and scientific analyses and had been validated by
the Celio Military Hospital, by the independent Research Institute
ViroStatics and by a recent range of tests developed by the
Department of Biomedical and Clinical Sciences of the University
of Milan (Italy). These last findings confirm what obtained in
the previous tests: an extraordinary efficacy of 90%.
This technology and its efficacy against respiratory viruses had
been reported by two recent issues on the periodical Viruses
(June 2023) and on the European Society of Medicine (October
2023).
e4life technology is constantly evolving and can be adapted
to an increasing number of viruses and, in a near future, to other
micro-organisms too (e.g. bacteria). Thanks to the constantly
evolving scientific research, these devices will be able to
inactivate an ever growing number of different pathogens.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240419226980/en/
e4life press office Mauro Perego - mauro.perego@elettrapr.it